Table 1.
Patient general characteristics.
| Variables | Controls (n = 36) | COVID-19 patients (n = 48) | p value |
|---|---|---|---|
| Gender | |||
| Male | 23 (63.90%) | 34 (70.80%) | 0.50 |
| Female | 13 (36.10%) | 14 (29.20%) | |
| Age (years) | |||
| Median (min-max) | 59.50 (36–82) | 63.50 (34–88) | 0.07 |
| BMI (kg/m2) | |||
| Median (min-max) | 28.95 (19.14–45) | 29.51 (20.76–41.03) | 0.79 |
| BMI <25 | 6 (16.67%) | 10 (20.83%) | 0.48 |
| M/F | 3/3 (50%; 50%) | 6/4 (60%; 40%) | 0.70 |
| Median (min-max) | 24 (19.14–24.69) | 23.52 (20.76–24.80) | |
| 25< BMI <30 | 14 (38.89%) | 16 (33.33%) | 0.31 |
| M/F | 11/3 (78.60%; 21.40%) | 14/2 (87.50%; 12.50%) | 0.51 |
| Median (min-max) | 27.34 (25–29.40) | 27.78 (25.95–29.76) | |
| BMI >30 | 16 (44.44%) | 22 (45.84%) | 0.16 |
| M/F | 9/7 (56.20%; 43.80%) | 14/8 (63.60%; 36.40%) | 0.65 |
| Median (min-max) | 31.85 (30.50–45) | 32.93 (30.12–41.03) | |
| Metabolic syndrome (yes) | 16 (44.40%) | 15 (31.20%) | 0.22 |
BMI is for body mass index.